{"id":"NCT01884519","sponsor":"GlaxoSmithKline","briefTitle":"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older","officialTitle":"Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2013/2014 in People 18 Years of Age and Above","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-07-01","primaryCompletion":"2013-08-02","completion":"2013-08-02","firstPosted":"2013-06-24","resultsPosted":"2014-12-01","lastUpdate":"2018-09-07"},"enrollment":120,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"Fluarix/Influsplit SSW® (2013-2014 season)","otherNames":[]}],"arms":[{"label":"Fluarix/Influsplit 18-60 Years Group","type":"EXPERIMENTAL"},{"label":"Fluarix/Influsplit > 60 Years Group","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess, in adults 18 years of age and above, the immunogenicity and reactogenicity of the seasonal influenza vaccine, Fluarix/Influsplit SSW 2013/2014, containing the three vaccine influenza strains (two A strains and one B strain) for the 2013/2014 season.","primaryOutcome":{"measure":"Humoral Immune Response in Terms of Haemagglutination Inhibition (HI) Antibody Titers Against Each of the Three Vaccine Influenza Strains","timeFrame":"At Day 0 and Day 21","effectByArm":[{"arm":"Fluarix/Influsplit 18-60 Years Group","deltaMin":27.3,"sd":null},{"arm":"Fluarix/Influsplit > 60 Years Group","deltaMin":15.7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":6,"exclusionCount":19},"locations":{"siteCount":4,"countries":["Germany"]},"refs":{"pmids":[],"seeAlso":["https://clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":60},"commonTop":["Pain","Myalgia","Fatigue","Headache","Redness"]}}